Literature DB >> 28688612

Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma: A Step Closer to Clinical Translation?

Cyrill A Rentsch1, David C Müller2, Christian Ruiz3, Lukas Bubendorf3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28688612     DOI： 10.1016/j.eururo.2017.06.022

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  13 in total

1.  Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36.

Authors:  Yudi Zhu; Shaosi Liang; Huafeng Pan; Zhongliang Cheng; Xin Rui
Journal:  J Biosci       Date:  2018-06       Impact factor: 1.826

2.  Identification of the gene expression changes and gene regulatory aspects in ELF3 mutant bladder cancer.

Authors:  Perihan Yagmur Guneri-Sozeri; Serap Erkek-Ozhan
Journal:  Mol Biol Rep       Date:  2022-02-24       Impact factor: 2.316

3.  Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer.

Authors:  BaiHeTiYa AZhaTi; Gaoliang Wu; Hailun Zhan; Wei Liang; Zhijian Song; Leilei Lu; Qichao Xie
Journal:  World J Surg Oncol       Date:  2022-07-12       Impact factor: 3.253

4.  Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance.

Authors:  Zhenqing Ye; Haidong Dong; Ying Li; Tao Ma; Haojie Huang; Hon Sing Leong; Jeanette Eckel-Passow; Jean-Pierre A Kocher; Han Liang; Liguo Wang
Journal:  Clin Cancer Res       Date:  2018-04-04       Impact factor: 12.531

5.  Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the 'trials within cohorts' study ProBCI.

Authors:  Anke Richters; Richard P Meijer; Niven Mehra; Joost L Boormans; Antoine G van der Heijden; Michiel S van der Heijden; Lambertus A Kiemeney; Katja K Aben
Journal:  BMJ Open       Date:  2021-05-18       Impact factor: 2.692

6.  Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism.

Authors:  Mohamed Elbadawy; Yomogi Sato; Takashi Mori; Yuta Goto; Kimika Hayashi; Megumi Yamanaka; Daigo Azakami; Tsuyoshi Uchide; Ryuji Fukushima; Toshinori Yoshida; Makoto Shibutani; Mio Kobayashi; Yuta Shinohara; Amira Abugomaa; Masahiro Kaneda; Hideyuki Yamawaki; Tatsuya Usui; Kazuaki Sasaki
Journal:  Cancer Biol Ther       Date:  2021-05-26       Impact factor: 4.875

7.  Significance of TP53 mutation in bladder cancer disease progression and drug selection.

Authors:  Guang Wu; Fei Wang; Kai Li; Shugen Li; Chunchun Zhao; Caibin Fan; Jianqing Wang
Journal:  PeerJ       Date:  2019-12-16       Impact factor: 2.984

8.  LncRNAs act as prognostic biomarkers in bladder carcinoma: A meta-analysis.

Authors:  Yucheng Zhong; Yeshen Zhang; Huan Li; Wenmin Ma
Journal:  Heliyon       Date:  2019-11-14

9.  Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer.

Authors:  Liping Shan; Wei Liu; Yunhong Zhan
Journal:  Aging (Albany NY)       Date:  2019-09-23       Impact factor: 5.682

Review 10.  Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer.

Authors:  Amira Abugomaa; Mohamed Elbadawy; Hideyuki Yamawaki; Tatsuya Usui; Kazuaki Sasaki
Journal:  Cells       Date:  2020-01-17       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.